Live feed16:01:00·1770dPRReleasevia QuantisnowMarinus Pharmaceuticals Reports Topline Ganaxolone Phase 2 Open-Label Results in Tuberous Sclerosis Complex and Receives FDA Orphan Drug DesignationByQuantisnow·Wall Street's wire, on your screen.MRNS· Marinus Pharmaceuticals Inc.Health Care
